Greenwich LifeSciences (GLSI) Revenue & Revenue Breakdown
Greenwich LifeSciences Revenue Highlights
00
Greenwich LifeSciences Revenue by Period
Greenwich LifeSciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
Greenwich LifeSciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $5.42K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | - |
Greenwich LifeSciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
AMLX | Amylyx Pharmaceuticals | $380.79M | $416.00K |
IMMP | Immutep | $3.51M | $2.11M |
MNOV | MediciNova | $1.00M | - |
EYEN | Eyenovia | $3.79K | $1.63K |
XFOR | X4 Pharmaceuticals | - | $560.00K |
RVPH | Reviva Pharmaceuticals | - | - |
PDSB | PDS Bio | - | - |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
NXTC | NextCure | - | - |
ACXP | Acurx Pharmaceuticals | - | - |
ENTX | Entera Bio | - | $42.00K |
TERN | Terns Pharmaceuticals | - | - |
VRPX | Virpax Pharmaceuticals | - | - |
AVXL | Anavex Life Sciences | - | - |
GLSI | Greenwich LifeSciences | - | - |